Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The standard multimodal pain management regimen (Bradbury) is a specific perioperative analgesic protocol utilized in clinical trials led by Thomas L. Bradbury, particularly for patients undergoing total knee arthroplasty (TKA). The regimen is designed to optimize pain control and reduce opioid consumption by targeting multiple pain pathways. It includes preoperative administration of intravenous dexamethasone (Decadron), intraoperative local infiltration with ropivacaine and intravenous ketorolac (Toradol), and a postoperative schedule of acetaminophen (Tylenol) combined with as-needed opioids such as oxycodone, morphine, or hydromorphone (Dilaudid). This multimodal approach aims to improve postoperative outcomes and patient recovery by providing comprehensive analgesia and managing inflammation associated with major orthopedic surgery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Standard multimodal pain management regimen (Bradbury).